Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency

被引:27
作者
Oezen, I
Rossmanith, W
Forss-Petter, S
Kemp, S
Voigtländer, T
Moser-Thier, K
Wanders, RJ
Bittner, RE
Berger, J
机构
[1] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria
[2] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria
[3] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands
[4] Med Univ Vienna, Inst Clin Neurol, A-1090 Vienna, Austria
关键词
D O I
10.1093/hmg/ddi125
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
X-linked adrenoleukodystrophy (X-ALD, OMIM 300100) is a severe inherited neurodegenerative disease, associated with the accumulation of very long-chain fatty acids (VLCFA). The recent unexpected observation that the accumulation of VLCFA in tissues of the Abcd1-deficient mouse model for X-ALD is not due to a deficiency in VLCFA degradation, led to the hypothesis that mitochondrial abnormalities might contribute to X-ALD pathology. Here, we report that in spite of substantial accumulation of VLCFA in whole muscle homogenates, normal VLCFA levels were detected in mitochondria obtained by organellar fractionation. Polarographic analyses of the respiratory chain as well as enzymatic assays of isolated muscle mitochondria revealed no differences between X-ALD and control mice. Moreover, analysis by electron microscopy, revealed normal size, structure and localization of mitochondria in muscle of both groups. Similar to the results obtained in skeletal muscle, the mitochondrial enzyme activities in brain homogenates of Abcd1-deficient and wild-type animals also did not differ. Finally, studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts of X-ALD patients and controls revealed no abnormalities. Thus, we conclude that the accumulation of VLCFA per se does not cause mitochondrial abnormalities and vice versa-mitochondrial abnormalities are not responsible for the accumulation of VLCFA in X-ALD mice.
引用
收藏
页码:1127 / 1137
页数:11
相关论文
共 42 条
[1]   ABNORMALITIES IN CULTURED MUSCLE AND PERIPHERAL-NERVE OF A PATIENT WITH ADRENOMYELONEUROPATHY [J].
ASKANAS, V ;
MCLAUGHLIN, J ;
ENGEL, WK ;
ADORNATO, BT .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (11) :588-590
[2]  
AUBOURG P, 1996, X LINKED ADRENOLEUKO
[3]   A mouse model for Zellweger syndrome [J].
Baes, M ;
Gressens, P ;
Baumgart, E ;
Carmeliet, P ;
Casteels, M ;
Fransen, M ;
Evrard, P ;
Fahimi, D ;
Declercq, PE ;
Collen, D ;
vanVeldhoven, PP ;
Mannaerts, GP .
NATURE GENETICS, 1997, 17 (01) :49-57
[4]   Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse) [J].
Baumgart, E ;
Vanhorebeek, I ;
Grabenbauer, M ;
Borgers, M ;
Declercq, PE ;
Fahimi, HD ;
Baes, M .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (04) :1477-1494
[5]   The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression [J].
Berger, J ;
Albet, S ;
Bentejac, M ;
Netik, A ;
Holzinger, A ;
Roscher, AA ;
Bugaut, M ;
Forss-Petter, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (02) :719-727
[6]   The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol [J].
Dammai, V ;
Subramani, S .
CELL, 2001, 105 (02) :187-196
[7]   DIFFERENTIAL INVESTIGATION OF THE CAPACITY OF SUCCINATE OXIDATION IN HUMAN SKELETAL-MUSCLE [J].
FISCHER, JC ;
RUITENBEEK, W ;
BERDEN, JA ;
TRIJBELS, JMF ;
VEERKAMP, JH ;
STADHOUDERS, AM ;
SENGERS, RCA ;
JANSSEN, AJM .
CLINICA CHIMICA ACTA, 1985, 153 (01) :23-36
[8]   ESTIMATION OF NADH OXIDATION IN HUMAN SKELETAL-MUSCLE MITOCHONDRIA [J].
FISCHER, JC ;
RUITENBEEK, W ;
TRIJBELS, JMF ;
VEERKAMP, JH ;
STADHOUDERS, AM ;
SENGERS, RCA ;
JANSSEN, AJM .
CLINICA CHIMICA ACTA, 1986, 155 (03) :263-273
[9]  
ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO
[10]  
2-W